Cargando…
Impact of Bevacizumab on Visual Function, Tumor Size, and Toxicity in Pediatric Progressive Optic Pathway Glioma: A Retrospective Nationwide Multicentre Study
SIMPLE SUMMARY: Around 30% of children with optic pathway glioma (OPG) require next order systemic anticancer therapy (SAT) in case of progression. Bevacizumab (BVZ) is considered an effective subsequent SAT for pediatric low grade glioma. This retrospective nationwide multicentre study evaluated th...
Autores principales: | Bennebroek, Carlien A. M., van Zwol, Judith, Porro, Giorgio L., Oostenbrink, Rianne, Dittrich, Anne T. M., Groot, Annabel L. W., Pott, Jan W., Janssen, Etienne J. M., Bauer, Noël J., van Genderen, Maria M., Saeed, Peerooz, Lequin, Maarten H., de Graaf, Pim, Schouten-van Meeteren, Antoinette Y. N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776082/ https://www.ncbi.nlm.nih.gov/pubmed/36551572 http://dx.doi.org/10.3390/cancers14246087 |
Ejemplares similares
-
Impact of systemic anticancer therapy in pediatric optic pathway glioma on visual function: A systematic review
por: Bennebroek, Carlien A. M., et al.
Publicado: (2021) -
Tocilizumab for the fifth progression of cystic childhood craniopharyngioma—a case report
por: de Vos-Kerkhof, Evelien, et al.
Publicado: (2023) -
RARE-62. VISUAL FUNCTION IN CHILDREN WITH CRANIOPHARYNGIOMA AT DIAGNOSIS: A SYSTEMATIC REVIEW
por: Nuijts, Myrthe, et al.
Publicado: (2020) -
Visual functions in children with craniopharyngioma at diagnosis: A systematic review
por: Nuijts, Myrthe A., et al.
Publicado: (2020) -
Gaze-Contingent Flicker Pupil Perimetry Detects Scotomas in Patients With Cerebral Visual Impairments or Glaucoma
por: Naber, Marnix, et al.
Publicado: (2018)